Homologous recombination repair and breast cancer gene testing in prostate cancer: expert perspectives and practical guidance on best practice from sample acquisition to biomarker-informed clinical decision-making - Top-Institutions - MDSpire

Homologous recombination repair and breast cancer gene testing in prostate cancer: expert perspectives and practical guidance on best practice from sample acquisition to biomarker-informed clinical decision-making

  • By

  • Eva Compérat

  • Gunhild von Amsberg

  • Lynda Corrigan

  • Stephen P. Finn

  • Glen Kristiansen

  • Angelo Minucci

  • David Olmos

  • Guilhem Roubaud

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Oncology

  • #2

    Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical Center

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Oncology

  • #4

    Translational Breast Cancer Research Consortium
    Translational Breast Cancer Research Consortium

    N/A, N/A

    Key Differentiators

    • Oncology

Original Source(s)

Homologous recombination repair and breast cancer gene testing in prostate cancer: expert perspectives and practical guidance on best practice from sample acquisition to biomarker-informed clinical decision-making

  • by Eva Compérat, Gunhild von Amsberg, Lynda Corrigan, Stephen P. Finn, Glen Kristiansen, Angelo Minucci, David Olmos, Guilhem Roubaud

  • July 1, 2026

Related Content

Established and emerging prognostic factors in mycosis fungoides and Sézary syndrome

Human Papillomavirus–Related Cancer in People With HIV and Solid Organ Transplant Recipients

Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma